Patient has a confirmed germline pathogenic variant in SMARCB1 (chromosome 22q11.2) or SM...
Детермінований перегляд YAML-сутності з джерельної бази. Клінічний авторитет лишається за вказаними source ID та статусом клінічного sign-off.
| ID | RF-RHABDOID-PREDISPOSITION-CONFIRMED-CARRIER |
|---|---|
| Тип | Тривожна ознака |
| Статус | переглянуто 2026-05-19 | очікує клінічного підпису |
| Хвороби | DIS-GLIOMA-LOW-GRADE |
| Джерела | SRC-FOULKES-RHABDOID-2017 SRC-NCCN-CNS-2025 SRC-NCCN-GENETIC-FAMILIAL-BREAST-OVARIAN-2025 |
Походження тривожної ознаки
| Визначення | Patient has a confirmed germline pathogenic variant in SMARCB1 (chromosome 22q11.2) or SMARCA4 (chromosome 19p13.2), defining rhabdoid tumor predisposition syndrome type 1 (RTPS1) or type 2 (RTPS2) respectively. Autosomal-dominant inheritance with near-100% penetrance for early-childhood disease in classic SMARCB1 cases. Cancer spectrum: atypical teratoid/rhabdoid tumor (ATRT) of the CNS with infancy peak, extracranial malignant rhabdoid tumor (MRT) of kidney / liver / soft tissue, small cell carcinoma of the ovary hypercalcemic type (SCCOHT — SMARCA4 specifically), and schwannomatosis in adolescent / adult survivors. The risk window is extremely narrow (peak ATRT incidence in the first 2 years of life) so high-cadence early surveillance is non-negotiable. Prevention-persona confirmed-carrier RedFlag (§20). |
|---|---|
| Клінічний напрям | investigate |
| Категорія | other |
Логіка спрацьовування
{
"any_of": [
{
"finding": "germline_smarcb1_pathogenic_confirmed",
"value": true
},
{
"finding": "germline_smarca4_pathogenic_confirmed",
"value": true
}
],
"type": "lab_value"
}
Нотатки
Prevention-persona Rhabdoid Tumor Predisposition Syndrome confirmed-carrier RedFlag (pediatric cancer predisposition Wave M). Engine routes to PreventionPlan for ATRT / MRT / (SMARCA4: SCCOHT) surveillance: brain MRI q3mo from infancy through age 4 then q6mo through age 5, whole-body MRI q3-6mo through age 5. SMARCA4 carriers additionally surveilled for SCCOHT (transvaginal US + pelvic exam starting menarche). Disease anchor DIS-GLIOMA-LOW-GRADE used as closest CNS anchor available in KB — ATRT is a distinct embryonal CNS entity, noted in rationale of paired Indications. STUB pending two-Clinical-Co-Lead signoff per CHARTER §6.1 dev-mode.
Де використовується
Indications
IND-RHABDOID-PREDISPOSITION-CARRIER-INTENSIFIED- IND-RHABDOID-PREDISPOSITION-CARRIER-INTENSIFIEDIND-RHABDOID-PREDISPOSITION-CARRIER-SURVEILLANCE- IND-RHABDOID-PREDISPOSITION-CARRIER-SURVEILLANCE